Wednesday Morning Movers

Galectin Therapeutics GALT +53% - Wednesday morning, the company announced positive results from the Phase 1 trial of GR-MD-02.

J C Penney Company JCP +19% - Reported holiday comparable sales up 3.7%; expects Q4 same store sales at upper end of range.

Procera Networks Inc. PKT +18% - Shares are higher following better than expected fourth quarter sales results.

Frontline Ltd. FRO +10% - CNBC contributor Karen Finerman offered positive comments on Frontline.

Arena Pharmaceuticals ARNA +9.9% - The company announced positive results from its phase 1b trial evaluating APD334.

Sonic Corporation SONC +7% - The company reported financial results.

First Solar Inc. FSLR +2.5% - Shares were upgraded to Buy at Standpoint Research; upgraded to Neutral at Goldman Sachs.

KalaBios Pharmaceuticals Inc. KBIO -60% - Late Tuesday, the company reported top-line data from phase 2 study of KB001-A.

Herbalife Ltd. HLF -3% - Bill Ackman On CNBC commented on Herbalife, suggesting the company will “miss EPS massively.”

Karyopharm Therapeutics KPTI -3% - The company announced a 3 million share offering.

Five Prime Therapeutics FPRX -2.2% - Shares are lower following announcement of a 3.41 million share offering.

Micron Technology MU -2.2% - The company reported financial results.

Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPre-Market OutlookMovers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...